X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
cardiovascular (11) 11
female (11) 11
male (11) 11
middle aged (11) 11
index medicus (10) 10
cardiac & cardiovascular systems (8) 8
treatment outcome (8) 8
aged (7) 7
heart attacks (7) 7
adult (6) 6
analysis (6) 6
cardiology and cardiovascular medicine (6) 6
drug-eluting stents (6) 6
abridged index medicus (5) 5
cardiology (5) 5
drug therapy (5) 5
stents (5) 5
clinical outcomes (4) 4
gastroenterology & hepatology (4) 4
internal medicine (4) 4
prospective studies (4) 4
stent (4) 4
time factors (4) 4
cancer (3) 3
coronary angiography (3) 3
hypertension (3) 3
immunosuppressive agents - pharmacology (3) 3
medical colleges (3) 3
percutaneous coronary intervention (3) 3
prognosis (3) 3
registries (3) 3
republic of korea (3) 3
sirolimus - pharmacology (3) 3
studies (3) 3
angiogenesis inhibitors (2) 2
angiography (2) 2
angioplasty, balloon, coronary (2) 2
angiotensin (2) 2
angiotensin receptor antagonists - administration & dosage (2) 2
angiotensin receptor antagonists - adverse effects (2) 2
angiotensin receptor antagonists - therapeutic use (2) 2
antagonists (2) 2
antihypertensive agents - administration & dosage (2) 2
antihypertensive agents - adverse effects (2) 2
antihypertensive agents - therapeutic use (2) 2
antineoplastic agents (2) 2
association (2) 2
biphenyl compounds - adverse effects (2) 2
biphenyl compounds - therapeutic use (2) 2
clinical-outcomes (2) 2
colorectal cancer (2) 2
comparative analysis (2) 2
coronary artery disease - diagnostic imaging (2) 2
coronary artery disease - therapy (2) 2
coronary disease (2) 2
coronary vessels (2) 2
diabetes (2) 2
diabetes-mellitus (2) 2
disease (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
drug therapy, combination (2) 2
everolimus (2) 2
fimasartan (2) 2
follow-up studies (2) 2
fractional flow reserve (2) 2
helicobacter pylori (2) 2
hypertension - drug therapy (2) 2
intravascular ultrasound (2) 2
kaplan-meier estimate (2) 2
lesions (2) 2
levofloxacin (2) 2
losartan (2) 2
medical education (2) 2
percutaneous coronary intervention - methods (2) 2
pharmacokinetics (2) 2
pharmacology & pharmacy (2) 2
predictive value of tests (2) 2
prosthesis design (2) 2
pyrimidines - adverse effects (2) 2
pyrimidines - therapeutic use (2) 2
randomized-trial (2) 2
recurrence (2) 2
research (2) 2
restenosis (2) 2
risk (2) 2
severity of illness index (2) 2
sirolimus - analogs & derivatives (2) 2
tetrazoles - adverse effects (2) 2
tetrazoles - therapeutic use (2) 2
transluminal angioplasty (2) 2
trial (2) 2
1st-line treatment (1) 1
2-year follow-up (1) 1
23s rrna (1) 1
24-hour ambulatory blood pressure monitoring (1) 1
2nd primary tumors (1) 1
3rd-line treatment (1) 1
active-control equivalence trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 9, pp. 1329 - 1338
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 5, pp. 641 - 646
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 20, pp. 2097 - 2109
Abstract Objectives The purpose of this study was to evaluate the clinical impact of chronic kidney disease (CKD) on clinical outcomes in contemporary practice... 
Cardiovascular | coronary artery disease | chronic kidney disease | clinical outcomes | percutaneous coronary intervention | chronic renal failure | drug-eluting stent(s)
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 5, pp. 733 - 743
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 3, pp. 382 - 394
Abstract Objectives A Bayesian network meta-analysis was performed comparing the efficacy and safety of drug-eluting balloons (DEB), drug-eluting stents (DES),... 
Cardiovascular | meta-analysis | drug-eluting balloons | drug-eluting stents | controlled trial | in-stent restenosis | randomized
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 4, pp. 409 - 415
Objectives This study sought to assess the relationship of coronary angiography, intravascular ultrasound (IVUS) and fractional flow reserve (FFR) between... 
Cardiovascular | coronary disease | intravascular ultrasound | ostium | fractional flow reserve
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 23, pp. e141 - e141
¬† Electrocardiography suggested ST-segment elevation myocardial infarction with underlying rhythm of atrial fibrillation (A). 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Atrial fibrillation | Heart attack | Cardiology | Heart attacks
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 6, pp. 1273 - 1289
Abstract Background Fimasartan is a selective angiotensin II receptor blocker developed for once-daily dosing. Objectives To meet the regulatory requirements... 
Internal Medicine | Medical Education | essential hypertension | 24-hour ambulatory blood pressure monitoring | efficacy | fimasartan | angiotensin II receptor blocker | tolerability | essential hypertension fimasartan | LOSARTAN | RECEPTOR BLOCKERS | ANGIOTENSIN | EPROSARTAN | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | TO-PEAK RATIO | TROUGH | ANTAGONISTS | IRBESARTAN | ENALAPRIL | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Biphenyl Compounds - adverse effects | Hypertension - drug therapy | Male | Biphenyl Compounds - therapeutic use | Tetrazoles - administration & dosage | Placebos | Adult | Female | Korea | Double-Blind Method | Administration, Oral | Pyrimidines - administration & dosage | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Pyrimidines - therapeutic use | Biphenyl Compounds - administration & dosage | Pyrimidines - adverse effects | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Measurement | Hypertension | Medical colleges | Medical research | Angiotensin | Medicine, Experimental | Blood pressure | Cardiology | Studies | Heart attacks | Drug therapy | Older people
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 3, pp. 552 - 568.e9
Abstract Background Angiotensin receptor blockers (ARBs) is an effective and well tolerated first-line antihypertensive drug. Fimasartan is a newly developed... 
Internal Medicine | Medical Education | angiotensin receptor blocker | losartan | hypertension | fimasartan | active-control equivalence trial | Hypertension | Fimasartan | Angiotensin receptor blocker | Losartan | Active-control equivalence trial | PERSISTENCE | HEART-FAILURE | BLOOD-PRESSURE | DISCONTINUATION | ATRIAL-FIBRILLATION | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | CANDESARTAN | RECURRENCE | ANTAGONISTS | VALSARTAN | Antihypertensive Agents - pharmacology | Prospective Studies | Tetrazoles - pharmacology | Humans | Middle Aged | Angiotensin Receptor Antagonists - pharmacology | Antihypertensive Agents - administration & dosage | Biphenyl Compounds - adverse effects | Hypertension - drug therapy | Male | Biphenyl Compounds - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Biphenyl Compounds - pharmacology | Adult | Female | Blood Pressure - drug effects | Hypertension - diagnosis | Republic of Korea | Severity of Illness Index | Double-Blind Method | Losartan - pharmacology | Treatment Outcome | Pyrimidines - pharmacology | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Pyrimidines - therapeutic use | Adolescent | Losartan - therapeutic use | Pyrimidines - adverse effects | Losartan - adverse effects | Tetrazoles - therapeutic use | Aged | Losartan - administration & dosage | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Medical colleges | Angiotensin | Antihypertensive drugs | Clinical trials | Cardiology | Comparative analysis | Hospitals | Drug therapy | Colleges & universities | Pharmaceuticals
Journal Article
Circulation, ISSN 0009-7322, 07/2004, Volume 110, Issue 3, pp. 301 - 308
Journal Article